Sweden

Dela

Välj datumintervall -
Taggar ( valda)

Global Genomics announces improved version of tangerine® gene expression profiling database covering

Global Genomics announces improved version of tangerine® gene expression profiling database covering 168 000 human transcripts Global GenomicsSM AB (Stockholm, Sweden) announced today the availability of an improved version of its tangerine® whole-genome expression profiling technology, substantially increasing coverage of the human, mouse and rat transcriptomes. By assembling transcriptomes much like genomes are assembled from individual sequence reads, researchers at Global Genomics were able to discover novel splice variants and alternative polyadenylation sites, as well as to correct

Global Genomics signs collaboration agreement with Rheoscience A/S

Global Genomics signs collaboration agreement with Rheoscience A/S Global Genomics(SM) AB (Stockholm, Sweden) announced today that Rheoscience A/S (Roedovre, Denmark) has entered into an agreement for the use tangerine® gene expression profiling to study targets in metabolic diseases. Ulf Boberg, CEO at Global Genomics stated, "This agreement is yet another confirmation of that researchers are demanding gene expression technologies that provide higher quality information. We are very excited about expanding our customer base and broadening customer awareness." About Rheoscience Rheoscience

Global Genomics' tangerine® gene expression profiling method published

Global Genomics' tangerine® gene expression profiling method published Researchers at Global Genomics(SM) AB (Stockholm, Sweden) are pleased to announce today's publication in the journal Nucleic Acids Research of the tangerine gene expression profiling method. The paper describes the advanced features of tangerine gene expression profiling - unbiased whole genome coverage, automatic combinatorial gene identification and sensitivity down to 7.5 parts per 10 million transcripts - and analyzes performance across multiple experiments. Citation: Metsis, et al. (2004) Whole-genome expression

Press Release August 30, 2004

Press Release August 30, 2004 tangerine® gene expression profiling receives registered trademark status in the U.S. Global Genomics(SM) AB has obtained a Certificate of Registration from the U.S. Patent and Trademark Office for the mark tangerine. Dr. Ulf Boberg, CEO of Global Genomics, stated, "This designation is another confirmation of the positive acceptance of our brand in the field of functional genomics. The company is building brand value not only with this registration, but through studies demonstrating the technology's exceptional performance in gene expression profiling." About

Global Genomics confirms superiority of tangerine gene expression profiling

Global Genomics confirms superiority of tangerine gene expression profiling Global Genomics AB revealed today the exceptional performance of the company's innovative technology for gene expression profiling. In a recent study tangerine® gene expression profiling demonstrated superior sensitivity in detecting gene expression when compared with a leading microarray platform. A set of well-characterized genes, that were randomly selected, was divided into three categories, corresponding to high, medium and low expression levels. While tangerine and the microarray platform performed equally

Global Genomics proposes state-of-the-art performance standards for FDA pharmacogenomics initiative

Global Genomics proposes state-of-the-art performance standards for FDA pharmacogenomics initiative Global Genomics has proposed state-of-the-art performance standards for gene expression profiling in a response to the recent draft document, "Guidance for Industry: Pharmacogenomics Data Submissions", from the United States Food and Drug Administration (FDA). Global Genomics AB is a Swedish-based biotechnology company developing tools for research into functional genomics. Dr. Ulf Boberg, CEO at Global Genomics, explained the importance of the FDA initiative, "Pharmacogenomic research deals

Det finns inga träffar som matchar nuvarande filter
Det finns inga fler träffar som matchar nuvarande filter
Tillbaka till sidans topp